Cargando…
S-1 induced hepatic steatosis in patients with pancreatic cancer: Retrospective analysis
AIM: To determine whether S-1 induces hepatic steatosis in patients being treated for pancreatic cancer. METHODS: This retrospective study evaluated 22 patients who received oral S-1 as a first-line treatment for pancreatic cancer between January 2008 and July 2015 at the Ishikawa Prefectural Centra...
Autores principales: | Tsuji, Kunihiro, Doyama, Hisashi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Baishideng Publishing Group Inc
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5561042/ https://www.ncbi.nlm.nih.gov/pubmed/28868111 http://dx.doi.org/10.4251/wjgo.v9.i8.314 |
Ejemplares similares
-
Evaluation of controlled attenuation parameter in assessing hepatic steatosis in patients with autoimmune liver diseases
por: Ni, Xi-Xi, et al.
Publicado: (2021) -
Liver intravoxel incoherent motion diffusion-weighted imaging for the assessment of hepatic steatosis and fibrosis in children
por: Shin, Hyun Joo, et al.
Publicado: (2018) -
Relationship between phase angle, steatosis, and liver fibrosis in patients coinfected with human immunodeficiency virus/hepatitis C virus
por: Fernandes, Sabrina Alves, et al.
Publicado: (2022) -
Testosterone therapy reduces hepatic steatosis in men with type 2 diabetes and low serum testosterone concentrations
por: Apostolov, Ross, et al.
Publicado: (2022) -
Two-point Dixon and six-point Dixon magnetic resonance techniques in the detection, quantification and grading of hepatic steatosis
por: Elfaal, Mohamed, et al.
Publicado: (2023)